Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,958.6
13.1 (0.45%)

 

  • STI Straits Times Index
    2,958.6
    13.1 (0.45%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,580.6
    5.3 (0.34%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,297.5
    -93.7 (-0.32%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,573.3
    3.9 (0.11%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,635.2
    89.0 (0.31%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,109.2
    -31.0 (-0.50%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 3,223.3M
  • Value: 1,250.2M
  • Rise: 216
  • Fall: 154
  • Unch: 407

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
China Star Food0.044-0.006
China Env Res0.023+0.010
Jiutian Chemical0.105-0.001
Asian Micro0.020-0.004
Artivision Tech0.012-
The Place Hldg0.145-0.020
Samko Timber0.046+0.008
MMP Resources^0.009-0.001
Guoan Intl0.014+0.004
Oceanus^0.052+0.001

World Indices

World Indices
Name Last Change
Nasdaq 13,626.1 -9.9
HSI 29,297.5 -93.7
HSCEI 11,651.2 -44.2
Jakarta 6,109.2 -31.0
Nikkei 225 28,635.2 +89.0
SSE Comp 3,573.3 +3.9
Shanghai A 3,745.6 +4.1
Shanghai B 247.5 +1.7
KOSPI 3,122.6 -17.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL CAN-FITE BIOPHARMA LTD. SPONSORED ADR
Updated on 26 Jan 2021 (End of trading day)
Last (USD): 2.050 Change: -0.040 High: 2.070 Remarks: -
Change (%): -1.91 Low: 2.010
Open 2.070 Yesterday's Close 2.09
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 357,925 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.62398 Trailing EPS (USD) e -0.86552 NAV (USD) b 0.6190
PE a - Trailing PE f - Price / NAV b 3.3118
Dividend (USD) d - Cash In Hand (USD) g 0.6632 Issued & Paid-up Shares c 15,414,000
Dividend Yield (%) d - Price / Cash In Hand g 3.091 Treasury Shares h -
Market Cap (M) 31.599 Enterprise Value (M) 21.369
Piotroski F Score 0 Exchange Code CANF Par Value ( $ ) n.a.
52 Weeks Volatility (%) 101.82 Free Float (%) -
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 27 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 17 Sep 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL NYSE American 31.599 - - 3.3118 -
Industry Biotechnology NYSE American 171.335 - - 4.4041 -
Local Peer ACTINIUM PHARMACEUTICALS INC NYSE American 657.773 - - 14.4795 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 359.978 - - 3.9441 -
Local Peer 22ND CENTURY GROUP INC NYSE American 276.424 - - 5.5247 -
Local Peer NANOVIRICIDES INC NYSE American 263.010 - - 8.7716 -
Local Peer IBIO INC NYSE American 159.649 - - 1.9942 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 154.513 - - 2.4052 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 152.802 - - 1.9849 -
Local Peer CEL-SCI CORP NYSE American 135.279 - - 6.8575 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 109.010 - - -12.6300 -
Local Peer AIM IMMUNOTECH INC NYSE American 87.476 - - 1.4488 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 68.075 - - 2.7651 -
Local Peer ORAGENICS INC NYSE American 51.738 - - 21.0000 -
Other Local Peers INDIA GLOBALIZATION CAPITAL INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American)
Global Peer AMGEN INC NASDAQ 150,548.903 19.198 20.477 13.7375 2.278
Global Peer CSL LTD ASX 125,208.845 39.922 39.922 13.2068 1.066
Global Peer GILEAD SCIENCES INC NASDAQ 83,610.451 15.524 65.939 4.7928 3.816
Global Peer VERTEX PHARMACEUTICAL NASDAQ 61,795.430 52.511 22.966 7.5977 -
Global Peer ILLUMINA INC NASDAQ 61,400.300 61.278 96.239 13.0639 -
Global Peer WUXI BIO HKEx 457,363.738 397.851 317.634 30.6176 -
Global Peer MODERNA INC NASDAQ 60,120.220 - - 21.7843 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 58,058.718 27.441 18.396 5.7339 -
Global Peer BIOGEN INC NASDAQ 41,805.123 7.099 8.225 3.8858 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 35,378.122 14.715 36.983 3.1944 -
Other Global Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), SEAGEN INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), SINO BIOPHARM (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ZAI LAB-SB (HKEx), BIO-TECHNE CORP (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), BLUEPRINT MEDICINES CORP (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), FIBROGEN INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), SEER INC (NASDAQ), INSMED INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), EDITAS MEDICINE INC (NASDAQ), IMMUNOVANT INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), ALKERMES PLC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), VERACYTE INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), GENSCRIPT BIO (HKEx), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALLOVIR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), 3SBIO (HKEx), STOKE THERAPEUTICS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), AURINIA PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), JW THERAP-B (HKEx), NANTKWEST INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), SANGAMO THERAPEUTICS INC (NASDAQ), JACOBIO-B (HKEx), SHATTUCK LABS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MYRIAD GENETICS INC (NASDAQ), VIELA BIO INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), VIVA BIOTECH (HKEx), REPLIMUNE GROUP INC (NASDAQ), REGENXBIO INC (NASDAQ), ALPHAMAB-B (HKEx), TRANSLATE BIO INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), PERSONALIS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), FRONTAGE (HKEx), BIOATLA INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), NKARTA INC (NASDAQ), PRECIGEN INC (NASDAQ), CYTOKINETICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ALECTOR INC (NASDAQ), HAOHAI BIOTEC (HKEx), JHBP-B (HKEx), POLYNOVO LIMITED (ASX), TRAVERE THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), ASCENTAGE-B (HKEx), LUMINEX CORP(DEL) (NASDAQ), INHIBRX INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), VAXCYTE INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), OMEROS CORP (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), MESOBLAST LTD (ASX), MERUS B V (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), VAXART INC (NASDAQ), COMPUGEN (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), HUMANIGEN INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), MIMEDX GROUP INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), KADMON HLDGS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), MANNKIND CORPORATION (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CURIS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CHIMERIX INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), AFFIMED N V (NASDAQ), AGENUS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), IMMATICS N V (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), ANAPTYSBIO INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), DPHARMA (Bursa), SQZ BIOTECHNOLOGIES CO (NYSE), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), KINTOR PHARMA-B (HKEx), HOMOLOGY MEDICINES INC (NASDAQ), SINOMAB BIO-B (HKEx), AKOUOS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), ATRECA INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), GERON CORP (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), ONCORUS INC (NASDAQ), BIOVIE INC (NASDAQ), OPTHEA LIMITED (ASX), SPRUCE BIOSCIENCES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), XOMA CORP (NASDAQ), CUE BIOPHARMA INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ASCLETIS-B (HKEx), ATHERSYS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), IMUGENE LIMITED (ASX), MAGENTA THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), LEE'S PHARM (HKEx), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), TREVENA INC (NASDAQ), NEXTCURE INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), KAMADA LTD (NASDAQ), BELLUS HEALTH INC (NASDAQ), ESSEX BIO-TECH (HKEx), PROQR THERAPEUTICS N V (NASDAQ), MEDICINOVA INC (NASDAQ), INMUNE BIO INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ADICET BIO INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), EVOGENE LTD (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), METACRINE INC (NASDAQ), CHIASMA INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), SESEN BIO INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), IMV INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), OTONOMY INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), IMMUTEP LTD (ASX), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), NEXT SCIENCE LTD (ASX), IMMUNOME INC (NASDAQ), ANTEOTECH LIMITED (ASX), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), ORGENESIS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ENZO BIOCHEM INC (NYSE), MINERVA NEUROSCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), CAPRICOR THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), COHBAR INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), SAVARA INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ADVAXIS INC (NASDAQ), BIONOMICS LTD (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), UNI-BIO GROUP (HKEx), DIFFUSION PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), RECRO PHARMA INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), CYNATA THERAPEUTICS LTD (ASX), LEAF RESOURCES LTD (ASX), ACORDA THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), BIOCARDIA INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), REGENT PACIFIC (HKEx), MEMPHASYS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), CATABASIS PHARMACEUTICALS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), PRECIPIO INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), ACHIEVE LIFE SCIENCE INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), PATRYS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), KIROMIC BIOPHARMA INC (NASDAQ), BIOTRON (ASX), AETERNA ZENTARIS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CT ENTERPRISE (HKEx), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), HISTOGEN INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), Suntar Eco-City (SGX), CONSTELLATION TECHNOLOGIES LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), REGENEUS LTD (ASX), CYCLO THERAPEUTICS INC (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), INMED PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), ADALTA LTD (ASX), SENECA BIOPHARMA INC (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), RHINOMED LIMITED (ASX), XENETIC BIOSCIENCES INC (NASDAQ), GEOVAX LABS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), BIO-PATH HOLDINGS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NANOLLOSE LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), CRYOSITE (ASX), PLUS THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), SENESTECH INC (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), HAO WEN HLDGS (HKEx), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.100
+5.13 %
10 Days -+0.130
+6.77 %
20 Days -+0.220
+12.02 %
Medium Term Return 3 Months -+0.390
+23.49 %
6 Months --0.410
-16.67 %
1 Year --0.303
-12.88 %
Long Term Return 2 Years --15.800
-88.52 %
3 Years --33.694
-94.26 %
5 Years --29.150
-93.43 %
Annualised Return Annualised --
-41.99 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.080 - 2.950 Change From 1 Year Low +0.970 % Change From 1 Year Low (%) +89.81
Change From 1 Year High -0.900 % Change From 1 Year High (%) -30.51
2 Years Range 1.080 - 24.300 Change From 2 Years Low +0.970 % Change From 2 Years Low (%) +89.81
Change From 2 Years High -22.250 % Change From 2 Years High (%) -91.56
5 Years Range 1.080 - 53.850 Change From 5 Years Low +0.970 % Change From 5 Years Low (%) +89.81
Change From 5 Years High -51.800 % Change From 5 Years High (%) -96.19
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Can-Fite BioPharma Ltd. engages in the development of drugs for cancer and inflammatory diseases. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.

Historical Price Data

Date Open High Low Close Volume VWAP
26 Jan 2021 2.070 2.070 2.010 2.050 357,925 -
25 Jan 2021 1.990 2.150 1.880 2.090 1,303,626 -
22 Jan 2021 1.980 2.000 1.960 1.990 222,923 -
21 Jan 2021 1.960 2.030 1.920 1.980 801,618 -
20 Jan 2021 1.880 1.980 1.880 1.950 526,647 -
19 Jan 2021 1.920 1.920 1.800 1.860 487,404 -
15 Jan 2021 1.850 1.930 1.820 1.900 403,671 -
14 Jan 2021 1.860 1.910 1.846 1.890 346,039 -
13 Jan 2021 1.920 1.935 1.870 1.920 364,355 -
12 Jan 2021 1.940 2.020 1.855 1.910 1,092,634 -
11 Jan 2021 1.860 1.930 1.860 1.910 322,789 -
08 Jan 2021 1.920 1.940 1.840 1.880 579,997 -
07 Jan 2021 1.880 1.934 1.860 1.870 369,411 -
06 Jan 2021 1.840 1.940 1.830 1.880 632,652 -
05 Jan 2021 1.850 1.870 1.810 1.850 152,861 -
04 Jan 2021 1.800 1.830 1.750 1.810 200,859 -
31 Dec 2020 1.800 1.830 1.750 1.780 303,958 -
30 Dec 2020 1.810 1.840 1.800 1.830 104,516 -
29 Dec 2020 1.840 1.850 1.800 1.820 267,675 -
28 Dec 2020 1.840 1.870 1.820 1.840 217,418 -
24 Dec 2020 1.830 1.930 1.830 1.850 217,902 -
23 Dec 2020 1.860 1.940 1.800 1.840 728,472 -
Summary
Current 2 Weeks
(12 Jan 2021 to 26 Jan 2021)
1.940 2.150 1.800 2.050 5,906,842 -
Previous 2 Weeks
(28 Dec 2020 to 11 Jan 2021)
1.840 2.150 1.800 1.910 3,152,136 -
4 Weeks from
(27 Nov 2020 to 24 Dec 2020)
1.820 2.150 1.790 1.850 14,578,499 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.